Myelodysplastic Syndrome: Diagnosis & Treatment at Memorial Sloan Kettering

Pictured: Martin Tallman Hematologist Martin Tallman, seen here on teaching rounds, evaluates such factors as bone marrow biopsy results and overall health in diagnosing and treating myelodysplastic syndromes.

Memorial Sloan Kettering’s Hematology Disease Management Team provides comprehensive, multidisciplinary care to more than 100 new patients with myelodysplastic syndromes (MDS) each year.

Our doctors conduct clinical trials to evaluate the latest therapies, and lecture at major conferences and institutions around the world. In addition, Memorial Sloan Kettering has been designated a Center of Excellence by the Myelodysplastic Syndromes Foundation.

Learn about how Memorial Sloan Kettering physicians diagnose, classify, stage, and treat patients with MDS.